KIMS — Krishna Institute of Medical Sciences Income Statement
0.000.00%
- IN₹288.06bn
- IN₹314.91bn
- IN₹30.35bn
Annual income statement for Krishna Institute of Medical Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 13,299 | 16,508 | 21,977 | 24,981 | 30,351 |
| Cost of Revenue | |||||
| Gross Profit | 7,346 | 9,471 | 11,752 | 13,403 | 16,383 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 10,268 | 12,037 | 17,215 | 20,038 | 24,282 |
| Operating Profit | 3,031 | 4,471 | 4,762 | 4,944 | 6,069 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2,790 | 4,569 | 4,849 | 4,596 | 5,581 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2,055 | 3,438 | 3,658 | 3,360 | 4,148 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 2,012 | 3,327 | 3,363 | 3,101 | 3,845 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2,012 | 3,327 | 3,363 | 3,101 | 3,845 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5.05 | 8.43 | 8.39 | 7.74 | 9.4 |
| Dividends per Share |